Spirostanol and sesquiterpenoid glycosides from the rhizomes of Trillium tschonoskii.
Antineoplastic Agents, Phytogenic
/ chemistry
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Glycosides
/ chemistry
HCT116 Cells
HeLa Cells
Humans
Models, Molecular
Molecular Conformation
Rhizome
/ chemistry
Sesquiterpenes
/ chemistry
Spirostans
/ chemistry
Structure-Activity Relationship
Trillium
/ chemistry
Tumor Cells, Cultured
Apoptosis
Cytotoxicity
Sesquiterpenoid glycoside
Spirostanol glycosides
Trillium tschonoskii
Journal
Steroids
ISSN: 1878-5867
Titre abrégé: Steroids
Pays: United States
ID NLM: 0404536
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
21
10
2019
revised:
09
12
2019
accepted:
20
12
2019
pubmed:
4
1
2020
medline:
28
1
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
Three new spirostanol glycosides, trilliumosides K-M (1-3), one new sesquiterpenoid glycoside, tritschsesuquiside A (4), along with three known analogues (5-7) were obtained from the rhizomes of Trillium tschonoskii. The structures of new glycosides were elucidated by spectroscopic analyses (HRMS and NMR) and chemical methods. Glycosides 5-7 displayed cytotoxicities against five human cancer cell lines with IC
Identifiants
pubmed: 31899263
pii: S0039-128X(19)30259-4
doi: 10.1016/j.steroids.2019.108569
pii:
doi:
Substances chimiques
Antineoplastic Agents, Phytogenic
0
Glycosides
0
Sesquiterpenes
0
Spirostans
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108569Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.